1. Home
  2. Detail

@adalah28pokoknya: #happybirthday #shahrukhkhan #srkfan #bollywoodsong #shahrukhkhanfan

ghitaaaa
ghitaaaa
Open In TikTok:
Region: ID
Sunday 01 November 2026 10:31:52 GMT
24462
2875
0
440

Music

Download

No Watermark .mp4 (1.74MB) No Watermark(HD) .mp4 (1.14MB) Watermark .mp4 (1.74MB) Music .mp3

Comments

There are no more comments for this video.
To see more videos from user @adalah28pokoknya, please go to the Tikwm homepage.

Other Videos

#اكسبلورexplore #لايك #foryourpage
#اكسبلورexplore #لايك #foryourpage
I hope my music speaks to your soul ❤️ Shillingi By A Pass now out everywhere 🎬 #Shillingi #APass
I hope my music speaks to your soul ❤️ Shillingi By A Pass now out everywhere 🎬 #Shillingi #APass
¿Descansas los jueves en las tardes? Acompañamos a nuestra clase de inglés desde cero de 6:00pm a 9:00pm. ⏰ 🌟 Ideal para quienes solo pueden estudiar inglés una vez a la semana. Te esperamos en el 5008 W Glendale Ave, Glendale AZ 85301. #AprendeIngles #AprendeIngles #ClasesDeIngles #GlendaleAZ
¿Descansas los jueves en las tardes? Acompañamos a nuestra clase de inglés desde cero de 6:00pm a 9:00pm. ⏰ 🌟 Ideal para quienes solo pueden estudiar inglés una vez a la semana. Te esperamos en el 5008 W Glendale Ave, Glendale AZ 85301. #AprendeIngles #AprendeIngles #ClasesDeIngles #GlendaleAZ
Missed Moderna’s 500% run? The bigger takeaway may be the industry, not the next stock. Some of the most important breakthroughs are happening far from semiconductors. One small Nasdaq company, Cellectar Biosciences (NASDAQ: CLRB), is developing a targeted radiotherapy designed to carry radiation directly into cancer cells. Its lead treatment has received both FDA Breakthrough Therapy and Fast Track designations. Next up is a confirmatory Phase 3 study, with an FDA accelerated approval submission planned for the first half of 2027. Disclosure: This content was disseminated on behalf of Cellectar Biosciences. The creator was compensated by a third-party to produce this content. This content is for informational and entertainment purposes only and should not be construed as financial or investment advice. Investing involves risk, and past performance does not guarantee future results. This is not financial advice. Viewers should conduct their own research and consult a licensed financial professional before making any investment decisions.
Missed Moderna’s 500% run? The bigger takeaway may be the industry, not the next stock. Some of the most important breakthroughs are happening far from semiconductors. One small Nasdaq company, Cellectar Biosciences (NASDAQ: CLRB), is developing a targeted radiotherapy designed to carry radiation directly into cancer cells. Its lead treatment has received both FDA Breakthrough Therapy and Fast Track designations. Next up is a confirmatory Phase 3 study, with an FDA accelerated approval submission planned for the first half of 2027. Disclosure: This content was disseminated on behalf of Cellectar Biosciences. The creator was compensated by a third-party to produce this content. This content is for informational and entertainment purposes only and should not be construed as financial or investment advice. Investing involves risk, and past performance does not guarantee future results. This is not financial advice. Viewers should conduct their own research and consult a licensed financial professional before making any investment decisions.
#viral #itoju #greatful #fyp
#viral #itoju #greatful #fyp
L’argent ne fait pas tout, mais sans lui, tout devient plus dur #realite #argent #verite #finance #probleme
L’argent ne fait pas tout, mais sans lui, tout devient plus dur #realite #argent #verite #finance #probleme

About

Legal